Complete Response Letters
Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc.: NDA 205508
What FDA's Complete Response Letters to the company say, in the letters' own words.
Complete Response Letter, Jul 28, 2025
Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc.
CRL_NDA205508_20250728:p1:s4The facility should provide satisfactory responses to these deficiencies to the FDA office indicated on the FDA Form 483 prior to your complete response submission to this application.
CRL_NDA205508_20250728:p1:s37Your complete response submission to this application should include the date(s) of the facility's response(s) to the FDA Form 483 observations.
CRL_NDA205508_20250728:p1:s41Prominently identify in your cover letter that the submission contains new CMC data.
CRL_NDA205508_20250728:p1:s48Plan to provide this clarification in your resubmission to this complete response letter (CRL).
CRL_NDA205508_20250728:p2:s28More Complete Response Letters
Updated Sep 30, 2026 · built from 283 companies in the EphemerisX knowledge graph. This page is regenerated as companies are added.